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Review question
Does coenzyme Q10 supplementation reduce mortality in patients with chronic heart failure?
 
Searches
A systematic search of electronic databases was conducted to identify articles relating to the outcomes of
CoQ10 in chronic heart failure. The following databases were used for searching, Ovid MEDLINE
(1946-October 19th), EMBASE (1973-October 18th), Cochrane Library, PubMed, ISI Web of Science, Allied
and Complimentary Medicines Database (AMED), and CINAHL Plus. The search started on October 16th
2018, and was conducted until November 10th 2018. The search was conducted without any restrictions on
type of study, time period, and language. Studies were included if they were randomised controlled trials
assessing the if supplementation with coenzyme Q10 reduces mortality in patients with chronic heart failure.
The following three terms were used as key words and medical subject headings where applicable (MeSH):
(“heart failure”), (“coenzyme Q10” or “ubiquinone” or “ubidercarenone”), and (“mortality” or “death”).
 
Types of study to be included
Randomised controlled trials.
The inclusion criteria: 
-Randomised controlled trials aiming to determine if CoQ10 supplementation will reduce mortality in patients
with chronic heart failure
-Patients aged over 18 years old
-Patients at any stage of the NYHA classification of heart failure
-Patients with heart failure due to left ventricular systolic dysfunction (LVSD), which is associated with a
reduced left ventricular ejection fraction, and also heart failure with a preserved ejection fraction, and left and
right sided heart failure.
The exclusion criteria: 
-Patients younger than 18 years old
-Patients with acute heart failure
-Observational studies, systematic reviews, meta-analyses, grey literature, abstracts only, unpublished
studies, quasi-randomised trials, and trials assessing the use of CoQ10 in other diseases.
 
Condition or domain being studied
Coenzyme Q10 supplementation affecting mortality in chronic heart failure patients.
 
Participants/population
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Adults above 18 years of age with chronic heart failure.
 
Intervention(s), exposure(s)
Exposure to the coenzyme Q10 supplement to assess its effects on mortality in patients with chronic heart
failure.
 
Comparator(s)/control
Placebo.
 
Context
 
Main outcome(s)
The use of the coenzyme Q10 supplementation in reducing mortality for patients with chronic heart failure.
Timing and effect measures
The effectiveness of this was measured by the outcomes of: 
Cardiovascular mortality 
 
Additional outcome(s)
Cardiac Function (echocardiography and cardiac peptides) 
Incidence of hospital stays
Improvement in NYHA class
NT-proBNP levels 
Occurrence of life-threatening events
Length of hospitalization 
Quality of life
Diastolic dysfunction 
Mitral regurgitation 
 
Data extraction (selection and coding)
All identified studies will be imported to Microsoft Excel for the manual removal of duplicate records. The
researcher will screen all titles and abstracts using the selection criteria. Then, the full text of eligible articles
will be screened independently by the researcher. Any disagreement or uncertainties about study inclusion
will resolved by discussion of the researcher with the reviewers. Upon retrieval of the full-text studies, the
references of those studies will also be hand-searched to ensure all relevant articles are obtained. 
The data will be extracted from the relevant studies using standardised tables to compare and contrast: 
- Study design
- Country
- Primary outcomes
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- Sample size
- Significance 
 
Risk of bias (quality) assessment
The quality assessment will be conducted using the COCHRANE Risk of Bias Tool. This will be conducted
by an independant reviewer, and discrepancies will be resolved with a second check by a second reviewer.
 
Strategy for data synthesis
We will provide a a descriptive review and a table of all findings from the included studies, which will present
the review, study design, sample size, and outcomes. Next, a descriptive analysis of aggregate study will be
used (tabulation of all data will be presented in the review). In the future, a meta-analysis is planned for
quantitative synthesis of the data. A second reviewer will cross check the findings of all studies.
 
Analysis of subgroups or subsets
None planned
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